Creatine Monohydrate In Myotonic Dystrophy: A Double-blind, Placebo-controlled Clinical Study
| Effect | Increase |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 34 |
| Sex | Both Genders |
| Age Range | 30-44, 45-64 |
| Body Types | Average |
Individuals with myotonic dystrophy received 10.6 g/day for 10 days followed by 5.3 g/day for 46 days. No effect was noted until the second half of the study (it was a cross-over design), when some of the parameters that worsened in the placebo group improved in the creatine group. The improvement was slight, if statistically significant, which suggest very minor therapeutic benefits.
